{"disease":{"id":"campylobacter-infections","name":"campylobacter infections"},"drugs":{"marketed":[{"drug_id":"doxycycline","indication_name":"Campylobacter fetus infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03683667","title":"Protein Plus: Improving Infant Growth Through Diet and Enteric Health","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":5283,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT06425250","title":"Campylobacter Spp. Bone and Joint Infection: a Retrospective Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04182490","title":"LMN-101 in a Campylobacter Human Challenge Model","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Lumen Bioscience, Inc.","has_results":true},{"nct_id":"NCT06432777","title":"Recurrent Campylobacter Bacteraemia in Immunocompromised Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}